Iteria Biopharma
PrivateLast Round
Seed
Apr 15, 2026
Total Funding Raised
$6.92M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Iteria Biopharma operates in Healthcare & Life Sciences and is based in Touro. Its latest recorded funding round was a Seed round in April 2026.
Iteria Biopharma is a biotechnology company that discovers and develops small-molecule drugs for the treatment of advanced metastatic cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iteria Biopharma Comparables
Compare Iteria Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AtG Therapeutics | 85% | |
| Oniria Therapeutics | 83% | |
| Nanoligent | 78% |
For institutional investors. Book with your work email.
Iteria Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 15, 2026 | ||||
| Grant | Dec 19, 2025 | ||||
| Debt | Nov 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Iteria Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inveready | Seed |
| Center for Technological Development and Innovation | Grant |
| Xesgalicia | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 57% MoM, reaching 1.2K.
- Jul 28, 2026
Monthly visitors increased 1439% MoM, from 51 to 785.
For institutional investors. Book with your work email.
Iteria Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Iteria Biopharma's valuation, stock price, and market status.
Is Iteria Biopharma a public or private company?
Iteria Biopharma is a private company.
What is the current stock price of Iteria Biopharma?
Iteria Biopharma is a private company, so its shares have no public market price. Caplight tracks Iteria Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Iteria Biopharma worth (valuation)?
Valuation information for Iteria Biopharma is not publicly available.
Can I buy Iteria Biopharma stock?
Iteria Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Iteria Biopharma's last funding round?
Iteria Biopharma's most recent funding round was Seed on April 15, 2026.
Who are the main investors in Iteria Biopharma?
Key investors in Iteria Biopharma include Inveready.
Will Iteria Biopharma IPO soon?
No public IPO plans have been announced for Iteria Biopharma.
How can I track Iteria Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in Iteria Biopharma's shares on secondary markets.